Targeting Tumor Microenvironment for Cancer Therapy
Open accessThe DOI matches its Crossref record; 209 of the 212 references it cites were found in a registry or an index.
Abstract
Cancer development is highly associated to the physiological state of the tumor microenvironment (TME). Despite the existing heterogeneity of tumors from the same or from different anatomical locations, common features can be found in the TME maturation of epithelial-derived tumors. Genetic alterations in tumor cells result in hyperplasia, uncontrolled growth, resistance to apoptosis, and metabolic shift towards anaerobic glycolysis (Warburg effect). These events create hypoxia, oxidative stress and acidosis within the TME triggering an adjustment of the extracellular matrix (ECM), a response from neighbor stromal cells (e.g., fibroblasts) and immune cells (lymphocytes and macrophages), inducing angiogenesis and, ultimately, resulting in metastasis. Exosomes secreted by TME cells are central players in all these events. The TME profile is preponderant on prognosis and impacts efficacy of anti-cancer therapies. Hence, a big effort has been made to develop new therapeutic strategies towards a more efficient targeting of TME. These efforts focus on: (i) therapeutic strategies targeting TME components, extending from conventional therapeutics, to combined therapies and nanomedicines; and (ii) the development of models that accurately resemble the TME for bench investigations, including tumor-tissue explants, “tumor on a chip” or multicellular tumor-spheroids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Main properties of in vitro 2D and 3D culture systems [187,188]. CAF, Cancer-associated fibroblast; ECM, Extracellular matrix.](https://figures.cochat.ai/paper-figures/5beab1962bf5470fbdf9b87661e2bff6/targeting-tumor-microenvironment-for-cancer-therapy-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dense ECM, abnormal vasculature, and an acidified environment all contribute to decreased drug penetration [83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared to the microenvironment of healthy tissue, the TME has augmented deposition of proteins such as collagen and fibronectin, high cytokine levels, increased proportion of fibroblasts and immune cells, and is immunosuppressive [82,83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“agents that degrade and/or deconstruct the ECM should be used cautiously, as they may lead to the release of factors that promote tumor progression and induce metastasis [83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Concerning the therapeutic outcome of such drugs, although they showed to improve patient survival, it has not been as great as expected, mostly related to the fact that patients stop responding or do not respond at all to these therapies, or even due to the side effects, for instance, the increased risk of arterial t…”
BackgroundElements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352 · cited 1×
“While some tumors present few signals of inflammation, others show a high number of immune cells either at the periphery or infiltrated within the tumor [70,71].”
BackgroundMacrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 3×
“Epithelial tumors display common features that allow for the setting of hallmarks that define cancer progression [7,8].”
BackgroundTumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“For this reason, tumors are frequently regarded as “wounds that never heal” [7,92].”
BackgroundTumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Research works printed but not linked: 1
- Larson B. 3D cell culture: A review of current techniques BioTek 2015 6 1 10
Cited by
Items 401–500 of 1,000
Wang, C., Cheng, T., Lu, Q., Li, W., Liu, B., Yue, L., Du, M., Sheng, W., Lu, Z., Yang, J., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106624 · Cited by 26
Liu, X., Ni, G., Zhang, P., Li, H., Li, J., Sebold, B. C., Wu, X., Chen, G., Yuan, S., & Wang, T. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02598-0 · Cited by 30
Lin, X., Yang, X., Yang, Y., Zhang, H., & Huang, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1132141 · Cited by 29
Valente, R., Cordeiro, S. Z., Luz, A., Melo, M. C., Roma‐Rodrigues, C., Baptista, P. V., & Fernandes, A. R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1310397 · Cited by 29
Self-citationCancer-on-chip: a breakthrough organ-on-a-chip technology in cancer cell modeling
Nejati, B., Shahhosseini, R., Hajiabbasi, M., Ardabili, N. S., Baktash, K. B., Alivirdiloo, V., Moradi, S., Rad, M. F., Rahimi, F., Farani, M. R., et al. (2024) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-024-03199-5 · Cited by 31
Toll-Like Receptors as Therapeutic Targets in Central Nervous System Tumors
Abarca-Merlin, D. M., Maldonado‐Bernal, C., & Alvarez-Arellano, L. (2019) · BioMed Research International · doi:10.1155/2019/5286358 · Cited by 25
Challenges and Opportunities for Childhood Cancer Drug Development
Houghton, P. J., & Kurmasheva, R. T. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.016972 · Cited by 27
Taniguchi, M., Ueda, Y., Matsushita, M., Nagaya, S., Hashizume, C., Arai, K., Kabayama, K., Fukase, K., Watanabe, K., Wardhani, L. O., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201901783rr · Cited by 29
Esophageal Microenvironment: From Precursor Microenvironment to Premetastatic Niche
Han, P., Cao, P., Hu, S., Kong, K., Deng, Y., Zhao, B., & Li, F. (2020) · Cancer Management and Research · doi:10.2147/cmar.s258215 · Cited by 27
Chu, Y., Zhu, C., Wang, Q., Liu, M., Wan, W., Zhou, J., Han, R., Yang, J., Luo, W., Liu, C., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16511 · Cited by 25
Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance
Loh, D., & Reiter, R. J. (2022) · Molecules · doi:10.3390/molecules27030705 · Cited by 26
Perspectives, Issues and Solutions in RNAi Therapy: the Expected and the Less Expected
Aigner, A. M. (2019) · Nanomedicine · doi:10.2217/nnm-2019-0321 · Cited by 28
Wang, T., Green, R. J., Howell, M., Martinez, T. E., Dutta, R., Mohapatra, S., & Mohapatra, S. S. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102294 · Cited by 27
Li, J., Li, H., Zhang, C., Zhang, C., & Wang, H. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107053 · Cited by 25
Huang, X., Zhang, J., & Zheng, Y. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.598221 · Cited by 26
Zhang, Y., You, W.-H., Li, X., Wang, P., Sha, B., Liang, Y., Qiu, J., Zhou, J., Hu, H., & Lu, L. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-2227 · Cited by 28
Five hypoxia and immunity related genes as potential biomarkers for the prognosis of osteosarcoma
Liu, D., Hu, Z., Jiang, J., Zhang, J., Hu, C., Huang, J., & Wei, Q. (2022) · Scientific Reports · doi:10.1038/s41598-022-05103-3 · Cited by 28
Wang, H., Chen, J., Li, S., Yang, J., Tang, D., Wu, W., Yu, K., Cao, Y., Xu, K., Yin, P., et al. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01819-3 · Cited by 26
Dillman, R. O., Nistor, G. I., & Keirstead, H. S. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2198467 · Cited by 28
Concave octahedral PtCu nanoframes mediated synergetic photothermal and chemodynamic tumor therapy
Zhai, J., Gao, J., Zhang, J., Liu, D., Gao, S., Yan, Y., Zhang, K., Cai, K., Yu, F., Lin, M., et al. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.136172 · Cited by 24
A review on polysaccharide-based tumor targeted drug nanodelivery systems
Tu, L., Xing, B., Ma, S., Zou, Z., Wang, S., Feng, J., Cheng, M., & Jin, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140820 · Cited by 23
Gut modulation to regulate NF-κB in colorectal and gastric cancer therapy and inflammation
Kearns, R. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-025-04118-9 · Cited by 27
Komarova, E. Y., Marchenko, L. V., Zhakhov, A. V., Nikotina, A. D., Aksenov, N., Suezov, R. V., Ischenko, A. M., Margulis, B. A., & Guzhova, I. V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010059 · Cited by 24
Pilankar, A., Singhavi, H. R., Raghuram, G. V., Siddiqui, S., Khare, N. K., Jadhav, V., Tandel, H., Pal, K., Bhattacharjee, A., Chaturvedi, P., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1000957 · Cited by 28
The prospect of tumor microenvironment-modulating therapeutical strategies
Eulberg, D., Frömming, A., Lapid, K., Mangasarian, A., & Barak, A. F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1070243 · Cited by 35
Functions of Key Enzymes of Glycolytic Metabolism in Tumor Microenvironment
Xu, W., Weng, J., Xu, M., Zhou, Q., Liu, S., Hu, Z., Ren, N., Zhou, C., & Shen, Y.-H. (2023) · Cellular Reprogramming · doi:10.1089/cell.2023.0010 · Cited by 25
Clinical Theranostics Trademark of Exosome in Glioblastoma Metastasis
Nag, S., Bhattacharya, B., Dutta, S., Mandal, D., Mukherjee, S., Anand, K., Eswaramoorthy, R., Thorat, N. D., Jha, S. K., & Gorai, S. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c00212 · Cited by 26
Acid-sensing ion channels and downstream signalling in cancer cells: is there a mechanistic link?
Gründer, S., Vanek, J., & Pissas, K. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-023-02902-z · Cited by 23
Yimin, E., Lü, Q., Zhu, K., Li, W., Sun, J., Ji, P., Meng, M., Liu, Z., & Yu, C. (2024) · iScience · doi:10.1016/j.isci.2024.109350 · Cited by 25
Prasad, S., Chandra, A., Cavo, M., Parasido, E., Fricke, S., Lee, Y., D’Amone, E., Gigli, G., Albanese, C., Rodriguez, O., et al. (2020) · Nanotechnology · doi:10.1088/1361-6528/abc208 · Cited by 30
Pro-tumoral functions of tumor-associated macrophage EV-miRNA
Cocks, A., Vecchio, F. D., Martinez‐Rodriguez, V., Schukking, M., & Fabbri, M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.08.001 · Cited by 28
Su, Y., Liu, J., Tian, Y., Dong, H., Shi, M., Zhang, J., Li, W., Huang, Q., Xiang, N., Wang, C., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116427 · Cited by 25
Tumor microenvironment and immunotherapy: from bench to bedside
Sinha, A., Ghosh, D., & Karati, D. (2025) · Medical Oncology · doi:10.1007/s12032-025-02818-x · Cited by 25
Revolutionizing cancer treatment: Nanotherapeutics targeting the tumor micro-environment
Joshi, D. C., Prasad, S., Bhati, V., Sharma, P. K., Joshi, N., Durgapal, S., Chavan, M. B., Maurya, V. K., Subramaniyan, V., Paudel, K. R., et al. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.115204 · Cited by 25
Zhao, M., Chang, J., Liu, R., Liu, Y., Qi, J., Wang, Y., Zhang, X., Qiao, L., Yu, J. H., An, H., et al. (2020) · 癌症:英文版 · doi:10.1002/cac2.12076 · Cited by 22
Uncovering the interplay between pH receptors and immune cells: Potential drug targets (Review)
Cao, L., Huang, T., Chen, X., Li, W., Yang, X., Zhang, W., Li, M., & Gao, R. (2021) · Oncology Reports · doi:10.3892/or.2021.8179 · Cited by 26
Zeng, N., Ma, L., Cheng, Y., Xia, Q., Li, Y., Chen, Y., Lu, Z., Lu, Q., Jiang, F., & Luo, D. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s327348 · Cited by 23
Zhou, L., Shen, J., Zhou, J., Hu, Y., & Xiao, H. (2022) · Scientific Reports · doi:10.1038/s41598-021-04591-z · Cited by 22
Message in a Bottle: Endothelial Cell Regulation by Extracellular Vesicles
Palazzo, C., D’Alessio, A., & Tamagnone, L. (2022) · Cancers · doi:10.3390/cancers14081969 · Cited by 23
Mechanism underlying circRNA dysregulation in the TME of digestive system cancer
Wu, Z., Yu, X., Zhang, S., He, Y., & Guo, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.951561 · Cited by 27
Fakhri, S., Moradi, S. Z., Faraji, F., Farhadi, T., Hesami, O., Iranpanah, A., Webber, K. J., & Bishayee, A. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10119-w · Cited by 25
The Multifaceted Effects of Autophagy on the Tumor Microenvironment
Kang, R., Zeh, H. J., Lotze, M. T., & Tang, D. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35727-6_7 · Cited by 24
Wang, J., Shi, W., Miao, Y., Gan, J., Guan, Q., & Ran, J. (2021) · Bioengineered · doi:10.1080/21655979.2021.1971029 · Cited by 23
Tumor heterogeneity and resistance in glioblastoma: the role of stem cells
Ghosh, N., Chatterjee, D., & Datta, A. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02123-y · Cited by 25
Xiao, R., Yang, M., Tan, Y., Ding, R., & Li, D. (2021) · Computational and Mathematical Methods in Medicine · doi:10.1155/2021/6676692 · Cited by 26
Neddylation Regulation of Immune Responses
Mao, H., Lin, X., & Sun, Y. N. (2023) · Research · doi:10.34133/research.0283 · Cited by 25
Identification of Key Genes in Thyroid Cancer Microenvironment
Zhao, K., Yang, H., Kang, H., & Wu, A. (2019) · Medical Science Monitor · doi:10.12659/msm.918519 · Cited by 25
Drug-internalized bacterial swimmers for magnetically manipulable tumor-targeted drug delivery
Xiang, Z., Jiang, G., Fan, D., Tian, J., Hu, Z., & Fang, Q. (2020) · Nanoscale · doi:10.1039/d0nr01892a · Cited by 21
Theranostic applications of smart nanomedicines for tumor-targeted chemotherapy: a review
Juthi, A. Z., Aquib, M., Farooq, M. A., Ghayas, S., Khalid, F., Boafo, G. F., Wande, D. P., Khan, D. H., Bithi, T. Z., Bavi, R., et al. (2020) · Environmental Chemistry Letters · doi:10.1007/s10311-020-01031-8 · Cited by 25
Wei, J., Fang, D., & Zhou, W. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-3301 · Cited by 22
Armani, G., Pozzi, E., Pagani, A., Porta, C., Rizzo, M., Cicognini, D., Rovati, B., Moccia, F. D., Pedrazzoli, P., & Ferraris, E. (2021) · Microvascular Research · doi:10.1016/j.mvr.2021.104189 · Cited by 23
Yang, R., Wang, D., Han, S., Gu, Y., Li, Z., Deng, L. H., Yin, A., Gao, Y., Li, X., Yu, Y., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.62602 · Cited by 23
Han, Z., Gong, C., Li, J., Guo, H., Chen, X., Jin, Y., Gao, S., & Tai, Z. (2021) · Materials Today Bio · doi:10.1016/j.mtbio.2021.100170 · Cited by 26
Progress of Immune Checkpoint Inhibitors Therapy for pMMR/MSS Metastatic Colorectal Cancer
Qu, F., Wu, S., & Yu, W. (2024) · OncoTargets and Therapy · doi:10.2147/ott.s500281 · Cited by 23
Lei, K., Zhou, L., Dan, M., Yang, F., Jian, T., Xin, J., Yu, Z., & Wang, Y. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030280 · Cited by 22
Embracing Mechanobiology in Next Generation Organ-On-A-Chip Models of Bone Metastasis
Slay, E., Meldrum, F. C., Pensabene, V., & Amer, M. H. (2021) · Frontiers in Medical Technology · doi:10.3389/fmedt.2021.722501 · Cited by 22
Feng, H., Wang, T., Ye, J., Yang, Y., Huang, X., Lai, D., Lv, Z., Huang, Y., & Zhang, X. (2022) · Discover Oncology · doi:10.1007/s12672-022-00592-0 · Cited by 23
Lipids and adipocytes involvement in tumor progression with a focus on obesity and diet
Calabrese, C., Miserocchi, G., Vita, A. D., Spadazzi, C., Cocchi, C., Vanni, S., Gabellone, S., Martinelli, G., Ranallo, N., Bongiovanni, A., et al. (2024) · Obesity Reviews · doi:10.1111/obr.13833 · Cited by 23
Wertel, I., Suszczyk, D., Pawłowska, A., Bilska, M., Chudzik, A., Skiba, W., Paduch, R., & Kotarski, J. (2020) · Journal of Immunology Research · doi:10.1155/2020/1715064 · Cited by 20
Han, Y., Wang, X., Xia, K., & Su, T. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-4990 · Cited by 28
Lee, C. H., Cho, J., & Lee, K. (2019) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2019.135 · Cited by 20
Andrgie, A. T., & Tsai, H. (2024) · Materials Advances · doi:10.1039/d4ma00122b · Cited by 21
Tertiary lymphoid structures in colorectal cancer
Lv, J., Zhang, X., Zhou, M., Yan, J., Chao, G., & Zhang, S. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2400314 · Cited by 25
Zuo, C., Xia, J., Xu, Y., Xu, Y., Gao, P., Zhang, J., Wang, Y., & Chen, L. (2025) · Nature Communications · doi:10.1038/s41467-025-60575-x · Cited by 27
Capula, M., Corno, C., Hassouni, B. E., Petri, G. L., Aranđelović, S., & on Behalf of the EORTC PAMM Group (2019) · Anticancer Research · doi:10.21873/anticanres.13485 · Cited by 22
Benchama, O., Tyukhtenko, S. I., Malamas, M. S., Williams, M. K., Makriyannis, A., & Avraham, H. K. (2022) · Scientific Reports · doi:10.1038/s41598-022-09358-8 · Cited by 24
Imparato, G., Urciuolo, F., Mazio, C., & Netti, P. A. (2022) · Lab on a Chip · doi:10.1039/d2lc00611a · Cited by 20
In Vitro and In Vivo Biological Activity of Ruthenium 1,10-Phenanthroline-5,6-dione Arene Complexes
Lenis-Rojas, O. A., Roma‐Rodrigues, C., Carvalho, B. G., Cabezas‐Sainz, P., Vila, S. F., Sanchez, L. E., Baptista, P. V., Fernandes, A. R., & Royo, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113594 · Cited by 24
Self-citationTumor-Derived Small Extracellular Vesicles Involved in Breast Cancer Progression and Drug Resistance
Feng, L., Guo, L., Tanaka, Y., & Su, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315236 · Cited by 20
Augimeri, G., Fiorillo, M., Morelli, C., Panza, S., Giordano, C., Barone, I., Catalano, S., Sisci, D., Andò, S., & Bonofiglio, D. (2023) · Cancers · doi:10.3390/cancers15030819 · Cited by 21
The role of extratumoral and intratumoral microorganisms in cancer immunotherapy
Du, Y., Liu, L., Ma, W., Yan, W., Mao, W., Du, Y., Cui, K., Pu, Y., Li, Z., Sansonetti, P. J., et al. (2023) · The Innovation Life · doi:10.59717/j.xinn-life.2023.100016 · Cited by 21
Unlocking the potential of the tumor microenvironment for cancer therapy
Tufail, M. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154846 · Cited by 22
Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy
Cao, J., Zhang, Z., Zhou, L., Luo, M., Li, L., Li, B., Nice, E. C., He, W., Zheng, S., & Huang, C. (2023) · MedComm · doi:10.1002/mco2.427 · Cited by 22
Biomechanical forces and force-triggered drug delivery in tumor neovascularization
Wendong, Y., Jiali, J., Fan, Q., Yayun, W., Xie, X., Zheng, S., & Huang, W. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116117 · Cited by 22
Chen, M., Xu, G., Fan, M., Jia, H., Xiao, L., & Lang, J. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1687498 · Cited by 20
Sphaerococcus coronopifolius bromoterpenes as potential cancer stem cell-targeting agents
Alves, C., Serrano, E., Silva, J., Rodrigues, C. F. D., Pintéus, S., Gaspar, H., Botana, L. M., Alpoim, M. C., & Pedrosa, R. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110275 · Cited by 20
Block copolymers for nanoscale drug and gene delivery
Zarrintaj, P., Yazdi, M. K., Bagheri, B., Kim, Y. C., Ramsey, J. D., & Saeb, M. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102985-5.00009-7 · Cited by 20
Wang, J., Zhao, J., Zhu, J., & Zhang, S. (2020) · Cancer Management and Research · doi:10.2147/cmar.s263768 · Cited by 19
Combined cancer therapeutics—Tackling the complexity of the tumor microenvironment
Roma‐Rodrigues, C., Raposo, L. R., Valente, R., Fernandes, A. R., & Baptista, P. V. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1704 · Cited by 25
Self-citationLin, Y., Wu, X., Zheng, C., Zhang, Q., Zhang, G.-Q., Chen, K., Zhan, Q., & An, F. (2021) · BioMed Research International · doi:10.1155/2021/8579658 · Cited by 19
Leong, T. K. M., Lo, W. S., Lee, W. E. Z., Tan, B., Lee, X. Z., Lee, L. W. J. N., Lee, J.-Y. J., Suresh, N., Loo, L., Szu, E., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113959 · Cited by 20
Xiao, Y., Zhang, L., Zhu, J., Zhang, Y., Yang, R., Yan, J., Huang, R., Zheng, C., Xiao, W., Huang, C., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112105 · Cited by 20
Dong, X., Yang, Y., Yuan, Q., Hou, J., & Wu, G. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.768140 · Cited by 19
Zhou, X., Guo, S., & Shi, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-06877-2 · Cited by 19
Yu, W., Chen, G., Yan, J., Wang, X., Zhu, Y., & Zhu, L. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03411-w · Cited by 20
Decellularized organ biomatrices facilitate quantifiable in vitro 3D cancer metastasis models
VandenHeuvel, S. N., Farris, H. A., Noltensmeyer, D. A., Roy, S., Donehoo, D. A., Kopetz, S., Haricharan, S., Walsh, A. J., & Raghavan, S. A. (2022) · Soft Matter · doi:10.1039/d1sm01796a · Cited by 20
Checkpoint Inhibitors in Cancer Therapy: Clinical Benefits for Head and Neck Cancers
Ettl, T., Grube, M., Schulz, D., & Bauer, R. J. (2022) · Cancers · doi:10.3390/cancers14204985 · Cited by 19
The role of CD8+ T-cells in colorectal cancer immunotherapy
He, T., Hu, C., Li, S., Fan, Y., Xie, F., Sun, X., Jiang, Q., Chen, W., Jia, Y., & Li, W. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33144 · Cited by 26
Autophagy in Viral Development and Progression of Cancer
Suares, A., Medina, M. V., & Coso, O. A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.603224 · Cited by 19
Characterization of the Safety Profile of Sweet Chestnut Wood Distillate Employed in Agriculture
Filippelli, A., Ciccone, V., Loppi, S., & Morbidelli, L. (2021) · Safety · doi:10.3390/safety7040079 · Cited by 18
Kamada, T., Haruki, K., Nakashima, K., Takahashi, J., Nakaseko, Y., Suzuki, N., Ohdaira, H., Eto, K., Ikegami, T., & Suzuki, Y. (2023) · Surgery Today · doi:10.1007/s00595-023-02646-4 · Cited by 19
Antitumor Therapy Targeting the Tumor Microenvironment
Gao, Y., Pan, Z., Li, H., & Wang, F. (2023) · Journal of Oncology · doi:10.1155/2023/6886135 · Cited by 22
Thipe, V. C., Jatar, A., Karikachery, A. R., Katti, K. K., & Katti, K. V. (2023) · Nanotechnology Science and Applications · doi:10.2147/nsa.s437812 · Cited by 21
He, Y., Jiang, P., Bian, M., Xu, G., Huang, S., & Sun, C. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106314 · Cited by 19
Al‐Ibraheem, A., Abdlkadir, A. S., Al-Rasheed, U., Al-Adhami, D. A., Istatieh, F., Anwar, F., Abdulrahman, M., Amarin, R., Mohamad, I., & Mansour, A. H. (2025) · Diagnostics · doi:10.3390/diagnostics15020218 · Cited by 18
Mohamed, M. F. A., Ahmed, E. A., Alshazly, O., Omran, O. A., Soomro, R. A., & Nafady, A. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.141651 · Cited by 18
Low Dose of Penfluridol Inhibits VEGF-Induced Angiogenesis
Srivastava, S., Zahra, F. T., Gupta, N., Tullar, P., Srivastava, S. K., & Mikelis, C. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030755 · Cited by 18
Song, Y. C., Lee, S. E., Jin, Y., Park, H. W., Chun, K., & Lee, H. (2020) · PubMed Central · doi:10.14348/molcells.2020.0118 · Cited by 29
Young, H. S., McGowan, L. M., Jepson, K. A., & Adams, J. C. (2020) · Bioscience Reports · doi:10.1042/bsr20193271 · Cited by 21
Žúbor, P., Wang, Y., Líšková, A., Samec, M., Koklesová, L., Daňková, Z., Dørum, A., Kajo, K., Dvorská, D., Lučanský, V., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217988 · Cited by 22
Metadata
- Authors
- Roma-Rodrigues, C., Mendes, R., Baptista, P. V., & Fernandes, A. R.
- Affiliations
- UCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa. Campus de Caparica, 2829-516 Caparica, Portugal
- Universidade Nova de Lisboa (PT)
- Corresponding author
- Baptista, Pedro V.
- Fernandes, Alexandra R.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-02-15
- Volume
- 20
- Issue
- 4
- Pages
- 840
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6413095
- OpenAlex
- W2913062750
- Cited by
- 1,187
- References
- 212
- Citations by year
- 2026: 76 · 2025: 134 · 2024: 156 · 2023: 229 · 2022: 186 · 2021: 216 · 2020: 139 · 2019: 47
- FWCI
- 14.04
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- Ministério da Ciência, Tecnologia e Ensino Superior (UID/Multi/04378/2019, SFRH/BPD/124612/2016)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- tumor microenvironment, cancer therapy, Warburg effect, tumor hypoxia, oxidative stress, extracellular matrix, tumor stromal cells, tumor-associated macrophages, angiogenesis, metastasis, exosomes, nanomedicine, combination therapy, tumor models, tumor-on-a-chip, tumor spheroids
- MeSH terms
- Animals, Humans, Models, Biological, Neoplasms, Neovascularization, Pathologic, Nanomedicine, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.